For the state, the cost of funding obesity medications was too high. For the patients, the cost of losing access is higher.

While GLP-1 receptor agonist medications like Ozempic, Semaglutide, and Wegovy have transformed the weight loss landscape, SlimCell offers a complementary, all-natural solution to help maintain and ...

CELLEV8 Launches First Post-GLP-1 Gummy Supplement: 'SlimCell™' with Clinically Proven Ingredients to Compliment GLP-1 ...

Ro partners with Eli Lilly to offer Zepbound, an FDA-approved obesity treatment, at affordable cash-pay prices through an ...

With the Biden administration pushing for Medicare, Medicaid coverage of GLP-1s, analysts disagree on whether it will ...

A slowdown of the digestive tract (gastroparesis) can be a serious side effect, though. Researchers who analyzed the health records of 16 million people revealed that pancreatitis and bowel ...

People struggling with their body weight experienced joy when new, more effective prescription drug options became the rage ...

Randomised controlled trials and real word evidence have consistently shown that GLP-1 receptor agonists are effective and ...

A recent New York Times story described a new fad: "microdosing" GLP-1 anti-obesity drugs like semaglutide (Ozempic, Wegovy) ...

Here are 10 major orthopedic studies conducted in 2024 to know: ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

Biotech leader says additional research into existing medications, drug classes, and mechanisms of action can bring forth ...